Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

35.74
Delayed Data
As of 3:50pm ET
 +0.145 / +0.41%
Today’s Change
30.89
Today|||52-Week Range
57.81
-0.32%
Year-to-Date
No recent news for Novo Nordisk.

Today’s Trading

Previous close35.60
Today’s open35.44
Day’s range35.42 - 35.80
Volume1,988,191
Average volume (3 months)3,644,471
Market cap$69.8B
Dividend yield3.71%
Data as of 3:50pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.05%
Revenue growth (last year)+3.81%
P/E ratio2.4
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca0.000.00%
ABTAbbott Laboratories-0.21-0.47%
SHPGShire+1.36+0.75%
LLYEli Lilly and Co+0.20+0.24%
Data as of 3:50pm ET, 02/27/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.54
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts


Search for Jobs